Finally Some Progress For Esophageal Cancer Patients– Two Immunotherapy Drugs Are Boosting Survival

Published Aug 31, 2020

Finally Some Progress For Esophageal Cancer Patients– Two Immunotherapy Drugs Are Boosting Survival

How immunotherapies are changing the treatment landscape for people with esophageal cancer, and how to know if you're a good candidate for one of these drugs.

NOW
PLAYING
$21 Billion Bet On Cancer Drug Trodelvy: What Does It Mean for Patients?
NOW
PLAYING
Making the Move to Maintenance Therapy
NOW
PLAYING
Real Solutions to Chemotherapy Side Effects
NOW
PLAYING
Relief for Chemotherapy Nausea
NOW
PLAYING
What the New Ovarian Cancer Drug Combo Approval Means for Patients
NOW
PLAYING
HER2-Positive Metastatic Breast Cancer Treatment Options
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.